CELLECTIS
Startup
CELLECTIS
Description
Cellectis develops TALEN® technology, an allogeneic CAR T-cell programs, allowing precise and targeted gene modification and providing new attributes to the product such as additional levels of safety or compatibility with the standard of care.
CELLECTIS
Address
8 RUE DE LA CROIX JARRY PARIS75013 FRANCE
FRANCE
FRANCE
Contact
Description
Cellectis develops TALEN® technology, an allogeneic CAR T-cell programs, allowing precise and targeted gene modification and providing new attributes to the product such as additional levels of safety or compatibility with the standard of care.
Matchmaking
Connect with CELLECTIS
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways